Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine
JAMA Oncol
.
2018 Nov 1;4(11):1484-1485.
doi: 10.1001/jamaoncol.2018.1940.
Author
Megan C Roberts
1
Affiliation
1
Division of Cancer Control and Population Sciences, The National Cancer Institute, Rockville, Maryland.
PMID:
29978191
DOI:
10.1001/jamaoncol.2018.1940
No abstract available
Publication types
Editorial
Comment
MeSH terms
Breast Neoplasms*
Cost-Benefit Analysis
Early Detection of Cancer
Humans
Mass Screening
Precision Medicine*